Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

To eat or not to eat: Is fasting still necessary before heart procedures?
As one may expect, patient satisfaction was considerably higher for individuals who did not have to fast for a minimum of six hours prior to treatment. There were no other significant differences.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).
Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.
Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.

New ORBITA data: Freedom from angina, stress echos improved with PCI

At EuroPCR in Paris, investigators of the controversial ORBITA trial presented two previously unreported benefits of percutaneous coronary intervention (PCI) for the study population.

HeartFlow Analysis Demonstrates Highest Diagnostic Performance for Detecting Heart Disease Compared to Other Non-Invasive Tests

PARIS, May 22, 2018 — HeartFlow, Inc. today announced new data from the PACIFIC trial showed that the HeartFlow Analysis had the highest diagnostic performance for detecting coronary artery disease (CAD), the most common form of heart disease, when compared to other commonly used non-invasive cardiac tests.

FFR-guided PCI linked to better 5-year outcomes than medical therapy

Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) was associated with a 54 percent reduction in the composite endpoint of death, myocardial infarction and urgent revascularization when compared to medical therapy alone, according to five-year data from the FAME 2 trial.

FDA approves new patient Medication Guides for all GBCAs

The FDA announced its approval of new patient Medication Guides for all gadolinium-based contrast agents (GBCAs) used for MRI, according to a recent press release.

Can coronary CT angiography accurately evaluate bioresorbable vascular scaffolds? Experts disagree

Coronary CT angiography (CTA) is diagnostically accurate in detecting scaffold luminal obstruction, according to a team of international researchers, signaling it may become the preferred method for evaluating patients treated with bioresorbable vascular scaffold (BVS)—but not all experts agree.

Fujifilm Introduces New Products, Supports Education, & Exhibits Pulmonary Imaging Portfolio at Ats 2018

FUJIFILM Medical Systems U.S.A., Inc. is exhibiting its portfolio of pulmonary imaging devices at the 114th annual international conference of the American Thoracic Society (ATS) in San Diego, CA, May 18 – 23.

For perfusion CMR analysis, quantitative tops qualitative for CAD prognosis

Researchers from Germany and the U.K. found quantitative analysis of perfusion cardiac magnetic resonance (CMR) ischemic burden superior to visual analysis in patients with suspected coronary artery disease (CAD), according to a recent Journal of the American College of Cardiology (JACC) study.

New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony

DUBLIN and BOSTON — May 11, 2018 — Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the Micra(TM) Transcatheter Pacing System (TPS) may restore AV synchrony, improving cardiac function in patients with sinus rhythm and atrioventricular (AV) block.

Cardiac Imaging

To eat or not to eat: Is fasting still necessary before heart procedures?

Pulmonary embolism thrombectomy use increases by more than 700%

Private equity-backed Medline files for IPO

Key takeaways for interventional cardiology from TCT 2025

FDA clears new AI-enabled coronary plaque analysis software